A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
Study Identifier
191622-133
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Male
Age
18 - 50 Years
Protocol Summary
This is a safety and efficacy study of OnabotulinumtoxinA for the treatment of premature ejaculation (PE) in male participants.
Study Locations
Location
Status
Location
San Diego Sexual Medicine
San Diego, California, United States, 92120
Status
Not applicable
Location
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, United States, 90502
Status
Not applicable
Location
Connecticut Clinical Research Center
Middlebury, Connecticut, United States, 06762
Status
Not applicable
Location
Center for Marital and Sexual Health of South Florida
West Palm Beach, Florida, United States, 33401
Status
Not applicable
Location
Tulane University School of Medicine
New Orleans, Louisiana, United States, 70112
Status
Not applicable
Location
Manhattan Medical Research
New York, New York, United States, 10016
Status
Not applicable
Showing {first} - {last} of {total} Results